Loading...
Edoxaban Plus Aspirin vs Dual Antiplatelet Therapy in Endovascular Treatment of Patients With Peripheral Artery Disease: Results of the ePAD Trial
Purpose: To report a randomized study that investigated the safety (risk of major bleeds) and potential efficacy of edoxaban, an oral anticoagulant that targets the major components of arterial thrombi, to prevent loss of patency following endovascular treatment (EVT). Methods: Between February 2012...
Saved in:
| Published in: | J Endovasc Ther |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
SAGE Publications
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5862321/ https://ncbi.nlm.nih.gov/pubmed/29552984 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1526602818760488 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|